| Quarter (USD) | Sep 24 | Jun 24 | Mar 24 | Dec 23 | |
|---|---|---|---|---|---|
| Revenue | |||||
| Cost of revenue | |||||
| Operating income | |||||
| Operating margin | |||||
| Net income | |||||
| Net profit margin | |||||
| Cash on hand | |||||
| Change in cash | |||||
| Diluted EPS |
| Annual (USD) | Dec 23 | Dec 22 | Dec 21 | Dec 20 | |
|---|---|---|---|---|---|
| Revenue | |||||
| Cost of revenue | |||||
| Operating income | |||||
| Operating margin | |||||
| Net income | |||||
| Net profit margin | |||||
| Cash on hand | |||||
| Change in cash | |||||
| Diluted EPS |
| Cash burn rate (est.) | Burn method: Change in cash | Burn method: Operating income | Burn method: FCF (opex + capex) | Last Q | Avg 4Q | Last Q | Avg 4Q | Last Q | Avg 4Q |
|---|---|---|---|---|---|---|
| Cash on hand (at last report) | 534.10 mm | 534.10 mm | 534.10 mm | 534.10 mm | 534.10 mm | 534.10 mm |
| Cash burn (monthly) | 25.34 mm | (no burn) | 35.22 mm | 26.21 mm | 24.88 mm | 20.25 mm |
| Cash used (since last report) | 101.92 mm | n/a | 141.65 mm | 105.40 mm | 100.05 mm | 81.46 mm |
| Cash remaining | 432.18 mm | n/a | 392.45 mm | 428.70 mm | 434.05 mm | 452.64 mm |
| Runway (months of cash) | 17.1 | n/a | 11.1 | 16.4 | 17.4 | 22.3 |
| 13F holders | Current |
|---|---|
| Total holders | 205 |
| Opened positions | 45 |
| Closed positions | 36 |
| Increased positions | 73 |
| Reduced positions | 55 |
| 13F shares | Current |
|---|---|
| Total value | 3.91 tn |
| Total shares | 129.18 mm |
| Total puts | 238.10 k |
| Total calls | 234.00 k |
| Total put/call ratio | 1.0 |
| Largest owners | Shares | Value |
|---|---|---|
| FMR | 9.03 mm | $324.24 bn |
| Atlas Venture Life Science Advisors | 8.02 mm | $288.08 bn |
| BlackRock | 7.79 mm | $279.96 bn |
| Vanguard | 6.86 mm | $246.56 bn |
| RTW Investments | 6.82 mm | $244.93 bn |
| JHG Janus Henderson | 6.81 mm | $244.76 bn |
| Ra Capital Management | 6.38 mm | $229.21 bn |
| FCPM Iii Services B.V. | 5.95 mm | $213.87 bn |
| Capital Fund IV Cooperatief U.A. Forbion | 5.80 mm | $169.23 mm |
| Atlas Venture Fund XI | 5.71 mm | $166.85 mm |
| Date | Owner | Security | Transaction | Code | Indirect | 10b5-1 | $Price | #Shares | $Value | #Remaining |
|---|---|---|---|---|---|---|---|---|---|---|
| 27 Jan 25 | Rhodes Jason P | Common Stock | Grant | Acquire A | Yes | No | 13.5 | 1,111,111 | 15.00 mm | 1,958,427 |
| 11 Dec 24 | Richard William Scalzo | Common Stock | Sell | Dispose S | No | Yes | 28.12 | 1,455 | 40.91 k | 127,078 |
| 11 Dec 24 | Oxana Beskrovnaya | Common Stock | Sell | Dispose S | No | Yes | 28.12 | 2,334 | 65.63 k | 201,685 |
| 9 Dec 24 | Dirk Kersten | Common Stock | Sell | Dispose S | Yes | No | 29.18 | 34,437 | 1.00 mm | 5,400,545 |
| 6 Dec 24 | Dirk Kersten | Common Stock | Sell | Dispose S | Yes | No | 29.34 | 101,675 | 2.98 mm | 5,434,982 |
| 4 Dec 24 | Johanna Friedl-Naderer | Common Stock | Grant | Acquire A | No | No | 0 | 37,800 | 0.00 | 96,200 |
| 4 Dec 24 | Johanna Friedl-Naderer | Stock option Common Stock | Grant | Acquire A | No | No | 29.44 | 60,300 | 1.78 mm | 60,300 |
